Fetal Alcohol Spectrum Disorders (FASD): an Approach to Effective Prevention by Roozen, Sylvia et al.
  
 
Fetal Alcohol Spectrum Disorders (FASD): an
Approach to Effective Prevention
Citation for published version (APA):
Roozen, S., Black, D., Peters, G-J., Kok, G., Townend, D., Nijhuis, J., ... Curfs, L. (2016). Fetal Alcohol
Spectrum Disorders (FASD): an Approach to Effective Prevention. Current Developmental Disorders
Reports, 3(4), 229-234. https://doi.org/10.1007/s40474-016-0101-y
Document status and date:
Published: 01/10/2016
DOI:
10.1007/s40474-016-0101-y
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
FETAL ALCOHOL SYNDROME (EF FURTADO, SECTION EDITOR)
Fetal Alcohol Spectrum Disorders (FASD):
an Approach to Effective Prevention
Sylvia Roozen1,2 & D. Black3 & G-J. Y. Peters1,4 & G. Kok1,2 & D. Townend1,5 &
J. G. Nijhuis1,6 & G. H. Koek1,7 & L. M. G. Curfs1,8
Published online: 26 October 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Purpose of Review The objective of the current contribution is
to propose an evidence-based, six-step approach to develop
effective programs for prevention of fetal alcohol spectrum
disorders.
Recent Findings Despite widespread campaigns aimed to re-
duce prenatal alcohol exposure, the number of affected chil-
dren continues to be high. Current strategies to reduce prenatal
alcohol exposure may be ineffective or counterproductive.
However, proven principles of health promotion could be ap-
plied to reduce drinking in pregnancy. One such approach is
Intervention Mapping (IM), a six-step procedure based on
proven principles to change behaviors.
Summary FASD affects all communities and is an
underestimated problem worldwide. Programs based on prov-
en principles of behavior change are warranted. Program de-
velopers can use pre-existing protocols and strategies from
evidence-based practice, such as Intervention Mapping.
Developers who plan their preventive programs in a system-
atic and evidence-based manner increase the chances of suc-
cess in reducing prenatal alcohol exposure and FASD.
Keywords Fetal alcohol syndrome . Fetal alcohol spectrum
disorder(s) . Health education . Prevention . Intervention .
Prenatal alcohol exposure
Introduction
Consumption of ethyl alcohol can have negative impact on
health and quality of life. As alcohol consumption is part of an
accepted way of life in many countries, the healthcare prob-
lems and costs are tremendous. Many persons are unaware of
the toxic effect of alcohol and its metabolites on different
organs of the body. Children, young adults, women, and in
particular pregnant women are very vulnerable to the effects
of alcohol that can have lifelong consequences. This is espe-
cially the case with fetal alcohol spectrum disorders (FASD).
FASD is an umbrella term for a range of birth defects caused
by prenatal exposure to ethyl alcohol. Alcohol results in mild
to severe damage to the development of the unborn baby
[1–3]. This damage leads to lifelong physical, behavioral,
and cognitive disabilities. Depending on the nature and sever-
ity of the damage, the following diagnoses under the FASD
umbrella can be given: fetal alcohol syndrome (FAS), partial
fe ta l a lcohol syndrome (pFAS) , a lcohol - re la ted
neurodevelopmental problems (ARND), alcohol-related birth
defects (ARBD), or neurobehavioral disorder-prenatal alcohol
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exposed (ND-PAE) [1, 4–8]. FASD is a 100 % preventable
disorder, as alcohol consumption during pregnancy can be
avoided. FASD is therefore one of the most important prevent-
able forms of non-genetic birth defects associated with mental
retardation [9–12]. This paper provides an overview of the
current state of FASD in relation to diagnostic procedures,
prevalence, and prevention, as well as making recommenda-
tions for the way forward in FASD prevention.
Diagnostics and Prevalence
FAS, first named in 1973, comprises several birth defects such
as growth deficiency (pre- and/or postnatal), facial
dysmorphology (short palpebral fissures, a thin upper lip,
smooth philtrum), or central nervous system dysfunction
(structural, neurological, or functional) [13]. In cases where
the full range of birth defects is not seen, other diagnostic
terms are used, and these are currently grouped under the
umbrella term FASD. Epidemiological studies have been con-
ducted in countries such as Australia, Canada, Italy, South
Africa, and the USA, with FASD prevalence prediction inter-
vals ranging from 0 to 176.77 per 1000 live births [14]. These
estimates are not easy to interpret as they are influenced by
factors such as the target group from which a sample was
taken and the guidelines applied for diagnosis. Indeed, the
difficulty of determining the prevalence goes hand-in-hand
with the difficulty of diagnosing the disorders.
Several initiatives have been undertaken to achieve a con-
sensus on establishing diagnoses within the spectrum of FASD
[15]. The Institute of Medicine (IOM) of the USA published a
first consensus in 1996 which was revised in 2005 and recently
updated [11, 16, 17]. Disagreement about the strictness of the
diagnostic criteria and their practical application remained.
Between 1997 and 2004, Astley and Clarren developed a 4-
digit diagnostic code to improve the objectivity of the diagnosis
[18]. In 2005, the Canadian guidelines were published, which
are considered to be midway between the IOM and the 4-digit
criteria [19]. In 2014, new diagnostic criteria for ND-PAE were
developed and proposed for further evaluation in the fifth edi-
tion of the Diagnostic and Statistical Manual [6, 7]. However,
the IOM guideline is currently the most commonly applied tool
[14, 17].
Prevention
Many approaches have been taken in the attempt to prevent
FASD. Some approaches are targeted to the general public,
including labels on drink containers, large-scale distributions
of posters, and flyers or media campaigns, such as the inter-
national campaigns taking place annually on September 9,
International FASDay [20]. Other approaches target
professionals, for example, accredited training sessions for
physicians and midwives. Still other programs focus on wom-
en at risk of an alcohol-exposed pregnancy or on pregnant
women. Such programs range from brief interventions to in-
tensive accompaniment during the pregnancy [21].
In many cases, there has unfortunately been inadequate
evaluation of the effectiveness of the intervention. For exam-
ple, many of the campaigns targeted to the public carry out no
evaluation at all, or the evaluation is based on the response to
questions about awareness of the risks associated with prena-
tal exposure to alcohol. It is often assumed that heightened
awareness of the risks will lead to stoppage of drinking during
pregnancy, yet this may not be the case.
A comparison with campaigns influencing smoking behav-
ior can be illuminating. For years, many different attempts
have been made to address smoking behavior, both effective
and ineffective. An ineffective approach is, for example, fear
appeal images and texts which are printed on cigarette pack-
ages. Research shows that fear appeal interventions are not
effective in changing behavior [22, 23]. For the development
of measures to prevent alcohol consumption during pregnan-
cy, we can learn from these studies and the use of evidence-
based strategies. Up to now, there has been little use of
evidence-based strategies to reduce alcohol consumption dur-
ing pregnancy [21]. The use of randomized control trials is an
exception rather than the rule.
Given the serious consequences, prevention of prenatal ex-
posure to alcohol is urgently needed. In order to go forward,
several recommendations can be made.
Recommendations
Prevention is the key in FASD whereby evidence-based prac-
tice is of utmost importance. First, it is essential to have a good
understanding of what is known and what is still unknown
about FASD. Evidence-based practice entails an integration
of scientific evidence and clinical expertise to form the basis
for FASD prevention and management. An iterative approach
can be used for the process of problem identification to solv-
ing the problem. In this effort, pre-existing protocols and strat-
egies can be used, such as Intervention Mapping (IM) [24,
25]. InterventionMapping is a planning approach that is based
on using theory and evidence as foundations for taking an
ecological approach to assessing and intervening in health
problems and engendering community participation [24]. IM
offers a methodology to systematically develop, implement,
and evaluate health promotion programs.
Each step of Intervention Mapping comprises several tasks
(Fig. 1). The completion of the tasks included in a step creates a
product that is the guide for the subsequent step. Completion of
all steps creates a blueprint for designing, implementing, and
evaluating an intervention based on a foundation of theoretical,
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empirical, and practical information. Although Intervention
Mapping comprises six steps, the process is iterative rather than
completely linear. Program developers move back and forth be-
tween tasks and steps as they gain new information and perspec-
tive. However, the process is also cumulative; planners base each
step on the previous steps, and inattention to a step can jeopardize
the potential effectiveness of later steps.
These six steps could be applied to the prevention of pre-
natal alcohol exposure and FASD as follows.
Step 1. Develop a logic model of the problem based on a
needs assessment.
The first step in development of a systematic evidence-
based health promotion program is to conduct a needs
assessment or problem analysis by identifying what, if
anything, needs to be changed and for whom. Planners
need to get a good understanding of the nature, extent,
and causes of the health problem before starting to devel-
op a program. The following questions may apply. Is
FASD a worldwide problem? The recently conducted
meta-analyses of global FASD prevalence estimates can
assist [14]. Data was only available for a limited number
of countries with FASD prevalence estimates ranging
from 0 to 176.77 per 1000 live births. Prevalence studies
varied considerably in terms of their methodology, so cau-
tion is warranted in interpreting the results; however, one
can conclude that FASD is indeed a worldwide problem
that merits more attention. As FASD is caused by prenatal
alcohol exposure, the question arises what maternal be-
haviors are related to FASD. There is no consensus on
what can be understood under harmful behavior and the
desired behavior among pregnant women. Some studies
report that heavily drinking pregnant women (Bbinge
drinking^) are more at risk of having a child with FASD
[26]. Other studies report that mild to moderate amounts
of alcohol consumption during pregnancy can already
have adverse effects on the outcome of the unborn child
[27]. Therefore, various international organizations such
as the World Health Organization (WHO), American
Academy of Pediatrics (AAP), National Institute of
Health (NIH), National Institute on Alcohol Abuse and
Alcoholism (NIAAA), and British Medical Association
(BMA) conclude that there is no known safe amount of
alcohol to consume while pregnant [11, 12, 28, 29]. To
elicit changes in behavior, it is, however, important to
Fig. 1 Intervention Mapping protocol [24]
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provide insight into the exact behaviors, as well as the
determinants and environmental factors which influence
these behaviors. Once this has been studied, it is essential
to determine who the highest at-risk target group is. For
FASD, this could be alcohol-dependent pregnant women,
women who are planning a pregnancy or women who
potentially might get pregnant. Furthermore, who are the
stakeholders involved who can contribute to the develop-
ment and implementation of the program [30]? The selec-
tion of important stakeholders is not straightforward, but
stakeholders potentially concerned with FASD include the
following: parents (biological and adoptive parents), per-
sons affected by FASD, the alcohol industry, government
(various departments), healthcare professionals, re-
searchers, and policy makers. Finally, what types of stig-
ma play a role and need to be considered while develop-
ing a program? Are there any further ethical consider-
ations to address [31, 32] ?
On the basis of the results of this first problem analysis, plan-
ners continue to step 2 to determine the program outcomes and
objectives that should lead to a decrease of the health problem.
Step 2. State program outcomes and objectives—a logic
model for change.
The second step is to create what are known as Bmatrices of
change objectives^ by combining behaviors and subsidiary
behaviors with behavioral determinants to identify which de-
terminants and beliefs should be targeted by the intervention
[33]. This step is not only conducted for the behaviors of the
at-risk target group, but repeated for behaviors required by
relevant stakeholders (e.g., midwives, general practitioners).
The analyses of relevant psychological determinants and en-
vironmental factors (both of which become desired interven-
tion outcomes) are based both on psychological theory and
empirical evidence. Moreover, relevant stakeholders are
consulted and involved.
Step 3. Develop the program plan, including scope, se-
quence, change methods, and practical applications.
The third step is to select theory-based behavior change
methods that match the determinants into which the iden-
tified sub-determinants aggregate and translate these into
practical applications that satisfy the parameters for effec-
tiveness of the selected methods [34]. For example, a
study by France and colleagues (2014) developed mes-
sages to increase women’s intention to abstain from alco-
hol while pregnant [35]. The authors combined risk infor-
mation and self-efficacy messages to achieve the goal of
intention to abstain from alcohol while pregnant. While
risk information alone was effective in increasing inten-
tion not to drink, theory suggests that threatening
messages alone may not change actual behavior. The ca-
pacity to change behavior depends also on self-efficacy
(one’s belief in the ability to succeed). Risk can be a
motivator for changing behavior when the message is fo-
cused on increasing or improving self-efficacy [24].
Step 4. Produce the intervention, including program mate-
rials and messages.
Once all components of the program have been developed,
these can be integrated into one coherent program. One exam-
ple is the brochure corresponding with the publication by
France and colleagues [35]. The fourth step is therefore based
on developing plans for pre-testing the program materials to-
gether with the planning group (including the target
population).
Step 5. Plan program use, including adoption, implementa-
tion, and maintenance.
The fifth step is to plan for adoption, implementation, and
sustainability of the program. Once a program has been de-
veloped, this in itself will not guarantee effectiveness. The
program users and implementers need to be identified. The
most obvious and important implementers for FASD preven-
tion are healthcare professionals in fields related to pregnancy.
Analysis of the stakeholders from the first step can assist in the
choice of implementers, as not all relevant stakeholders are
motivated or in a position to carry out a program. The process
and considerations for adoption, implementation, and sustain-
ability of programs are often not reported.
Step 6. Develop an evaluation plan.
The sixth step is to generate an evaluation plan to measure
program effectiveness. For each of the objectives from step 2,
a measurable outcome should be determined. Then, the plan-
ners specify the evaluation design to conduct effect and pro-
cess evaluations.
Conclusions
FASD is an important health problem which affects indi-
viduals and their families worldwide. FASD is caused by
prenatal alcohol exposure and is therefore, theoretically,
entirely preventable. Development of effective interven-
tions, however, is complex, and if key factors are
overlooked, an ineffective or counterproductive program
may be the result. Program developers can use pre-
existing protocols and evidence-based strategies, such as
the Intervention Mapping approach described here.
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